Abivax S.A. (ABVX) — Earnings Call Analysis & IR Page

Abivax S.A is a Healthcare company operating in Biotechnology with a $9.91B market cap.

Most recent earnings call: Q4 FY23 on Apr 8, 2024.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.80

ir.abivax.com

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 1 calls

Q4 FY2023
Earnings
2024-04-088 Q&A exchanges

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ABVX.

$ curl https://api.spokenalpha.com/v1/companies/ABVX

Get an API key API docs

FAQ

Frequently asked about ABVX

Where can I find Abivax S.A.'s (ABVX) earnings call transcripts?

Spoken Alpha indexes ABVX's earnings call transcripts at https://spokenalpha.com/companies/ABVX. Each call links to attributed speakers and parsed analyst Q&A. Abivax S.A.'s own investor relations page is at https://ir.abivax.com/.

When was Abivax S.A.'s most recent earnings call?

Abivax S.A. (ABVX) held its most recent earnings call on 2024-04-08, covering fiscal Q4 2023.

What sector is ABVX in?

Abivax S.A. (ABVX) operates in the Healthcare sector (Biotechnology industry).

Overview